Evaluation of the Impact of Marijuana Use on Semen Quality: a Prospective Analysis
Overview
Authors
Affiliations
Aims: To assess if marijuana consumption - prevalent among men of reproductive age and becoming widespread due to decriminalization - is associated with changes in semen parameters. Marijuana's active metabolite, tetrahydrocannabinol, can alter signaling pathways within spermatozoa, affecting spermatogenesis and fertility.
Methods: We prospectively evaluated semen analyses (SA) from men presenting for infertility evaluation at one institution from July 2017 to April 2018. Participants completed a reproductive health questionnaire including items regarding marijuana consumption. SA was performed in accordance with World Health Organization (WHO) 5th Edition criteria. SA parameters included volume (ml), concentration (million/ml), motility (%), progressive motility (%), and Tygerberg strict morphology (%).
Results: A total of 409 patients completed the questionnaire; 174 (43%) men reported marijuana use (ever-users). Current and past users comprised 71 (17%) and 103 (25%), respectively. Compared with never-users, current and past users had a significantly higher likelihood of abnormal sperm strict morphology (33.1% 50.7% and 53.4%, respectively; < 0.001). However, sperm motility was more likely to be less than WHO reference values in never-users than current and past-users (38.3% 21.1% and 27.2%, respectively; = 0.01). In multivariate logistic regression analyses, current use was associated with increased odds of abnormal strict morphology [odds ratio (OR) 2.15, 95% confidence interval (CI): 1.21-3.79] and semen volume less than WHO reference value (OR 2.76, 95%CI: 1.19-6.42), while odds of less than WHO reference value sperm motility were reduced (OR 0.47, 95%CI: 0.25-0.91).
Conclusion: Marijuana use is common among men presenting for fertility evaluation, and may have a detrimental effect on semen quality, particularly morphology and volume, but may be protective against abnormal sperm motility. Large, prospective studies of both semen quality and fertility in this growing, at-risk population are warranted.
Amor H, Ismaeil A, Jankowski P, Smadi M, Zoubi M, Juhasz-Boss I Sci Rep. 2025; 15(1):7547.
PMID: 40038427 PMC: 11880194. DOI: 10.1038/s41598-025-91894-0.
Floccari S, Sabry R, Choux L, Neal M, Khokhar J, Favetta L BMC Pharmacol Toxicol. 2024; 25(1):42.
PMID: 39010179 PMC: 11247865. DOI: 10.1186/s40360-024-00763-5.
Sperm morphology: Evaluating its clinical relevance in contemporary fertility practice.
Pelzman D, Sandlow J Reprod Med Biol. 2024; 23(1):e12594.
PMID: 38915912 PMC: 11194684. DOI: 10.1002/rmb2.12594.
Influence of substance use on male reproductive health and offspring outcomes.
Lo J, Hedges J, Chou W, Tager K, Bachli I, Hagen O Nat Rev Urol. 2024; 21(9):534-564.
PMID: 38664544 DOI: 10.1038/s41585-024-00868-w.
Kuzma-Hunt A, Sabry R, Davis O, Truong V, Khokhar J, Favetta L PLoS One. 2024; 19(3):e0298697.
PMID: 38536780 PMC: 10971525. DOI: 10.1371/journal.pone.0298697.